The chemical class known as CECR2 activators encompasses a group of compounds that modulate the activity of the calcium-binding protein CECR2, standing for Cat Eye Syndrome Chromosome Region, Candidate 2. CECR2 is associated with chromatin remodeling, and its activation or modulation plays a pivotal role in the regulation of various cellular processes. Structurally, CECR2 activators often interact with specific binding sites on the protein, inducing conformational changes that subsequently impact its functional properties. These activators can act as allosteric modulators, influencing the protein's ability to bind to chromatin and participate in epigenetic regulation.
The precise mechanisms through which CECR2 activators exert their effects remain an active area of research. Some compounds may enhance the affinity of CECR2 for its binding partners, while others may alter its intracellular localization. Understanding the structural and biochemical details of CECR2 activation is crucial for unraveling the intricate web of cellular events regulated by this protein. As researchers delve deeper into the molecular intricacies of CECR2 activation, the potential implications for cellular physiology and function become increasingly apparent. The exploration of CECR2 activators sheds light on the dynamic interplay between chromatin remodeling proteins and cellular processes, contributing to the broader understanding of molecular mechanisms governing gene expression and cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC Inhibitor; Enhances histone acetylation, potentially indirectly activating CECR2 by modulating the acetylation status of histones. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC Inhibitor; Induces histone hyperacetylation, potentially indirectly activating CECR2 by altering the acetylation state of histones. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC Inhibitor; Alters histone acetylation levels, potentially activating CECR2 by modulating the acetylation status of histones. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
HAT Activator; Enhances histone acetylation, potentially indirectly activating CECR2 through promotion of histone acetylation. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
HAT Activator; Modulates histone acetylation, potentially activating CECR2 by influencing the acetylation state of histones. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BRD4 Inhibitor; Targets bromodomain-containing proteins, possibly indirectly activating CECR2 through modulation of the bromodomain-dependent chromatin interactions. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
p300/CBP Inhibitor; Blocks histone acetylation, potentially indirectly activating CECR2 by disrupting the histone acetylation machinery. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K Inhibitor; Modulates PI3K/Akt signaling, potentially indirectly activating CECR2 by influencing the PI3K/Akt pathway, which may intersect with CECR2-related processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR Inhibitor; Inhibits mTOR signaling pathway, potentially indirectly activating CECR2 through modulation of the mTOR pathway, which could be connected to CECR2-related functions. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Tankyrase Inhibitor; Modulates Wnt/β-Catenin pathway, potentially indirectly activating CECR2 by influencing the Wnt/β-Catenin pathway, which may intersect with CECR2-related processes. | ||||||